[1] Mazzolai L, Teixido-Tura G, Lanzi S, et al.2024 ESC Guidelines for the management of peripheral arterial and aortic diseases[J]. Eur Heart J, 2024,45(36):3538-3700.
[2] Ferreira H B, Trindade F, Nogueira-Ferreira R, et al.Lipidomic insights on abdominal aortic aneurysm and peripheral arterial disease[J]. J Mol Med (Berl), 2025,103(4):365-380.
[3] Gao J, Guo W.Mechanisms of abdominal aortic aneurysm progression: A review[J]. Vasc Med, 2022,27(1):88-96.
[4] Nana P, Dakis K, Brodis A, et al.Circulating Biomarkers for the Prediction of Abdominal Aortic Aneurysm Growth[J]. J Clin Med, 2021,10(8).
[5] Wanhainen A, Verzini F, Van Herzeele I, et al.Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms[J]. Eur J Vasc Endovasc Surg, 2019,57(1):8-93.
[6] Forsdahl S H, Singh K, Solberg S, et al.Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso Study, 1994-2001[J]. Circulation, 2009,119(16):2202-2208.
[7] Iribarren C, Darbinian J A, Go A S, et al.Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study[J]. Ann Epidemiol, 2007,17(9):669-678.
[8] Takagi H, Manabe H, Kawai N, et al.Serum high-density and low-density lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis[J]. Int Angiol, 2010,29(4):371-375.
[9] Kubota Y, Folsom A R, Ballantyne C M, et al.Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study[J]. Atherosclerosis, 2018,268:63-67.
[10] Golledge J, Thanigaimani S, Powell J T, et al.Pathogenesis and management of abdominal aortic aneurysm[J]. Eur Heart J, 2023,44(29):2682-2697.
[11] Mazzotti D R, Singulane C C, Ota V K, et al.Association of APOE, GCPII and MMP9 polymorphisms with common diseases and lipid levels in an older adult/elderly cohort[J]. Gene, 2014,535(2):370-375.
[12] Shen Z, Zhu D, Liu J, et al.27-Hydroxycholesterol induces invasion and migration of breast cancer cells by increasing MMP9 and generating EMT through activation of STAT-3[J]. Environ Toxicol Pharmacol, 2017,51:1-8.
[13] Yin J, Chaufour X, McLachlan C, et al. Apoptosis of vascular smooth muscle cells induced by cholesterol and its oxides in vitro and in vivo[J]. Atherosclerosis, 2000,148(2):365-374.
[14] Kajani S, Curley S, McGillicuddy F C. Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within[J]. Int J Mol Sci, 2018,19(7).
[15] Burillo E, Lindholt J S, Molina-Sanchez P, et al.ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression[J]. Thromb Haemost, 2015,113(6):1335-1346.
[16] Takagi H, Manabe H, Umemoto T.A meta-analysis of association between serum lipoproteins and abdominal aortic aneurysm[J]. Am J Cardiol, 2010,106(5):753-754.
[17] Jia C, Anderson J L C, Gruppen E G, et al. High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events[J]. Circulation, 2021,143(20):1935-1945.
[18] Tran-Dinh A, Diallo D, Delbosc S, et al.HDL and endothelial protection[J]. Br J Pharmacol, 2013,169(3):493-511.
[19] Garner B, Waldeck A R, Witting P K, et al.Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII[J]. J Biol Chem, 1998,273(11):6088-6095.
[20] Krishna S M, Seto S W, Moxon J V, et al.Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model[J]. Am J Pathol, 2012,181(2):706-718. |
